ArticleClinical and molecular hepatology2024

Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer.

Pin-Nan Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.